eighty-nine patients with multiple myeloma resistant to melphalan were randomized to receive cyclophosphamide plus prednisone ( cp ) ( 47 patients ) or cyclophosphamide plus bcnu plus prednisone ( cbp ) ( 42 patients ) .
C0026764
multiple myeloma
C0025241
melphalan